- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Fragment-based Drug Discovery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Fragment-based Drug Discovery size is estimated to be USD 435.9 million in 2026 from USD 342.4 million in 2020, with a change XX% between 2020 and 2021. The global Fragment-based Drug Discovery market size is expected to grow at a CAGR of 6.2% for the next five years.
Market segmentation
Fragment-based Drug Discovery market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Fragment Screening
Fragment Optimization
Market segment by Application, can be divided into
Academic and Research Institutions
Biopharmaceutical Companies
Contract Research Organizations (CROs)
Market segment by players, this report covers
Astex Pharmaceuticals
Alveus Pharmaceuticals
Beactica
Charles River Laboratories
Crown Bioscience
Emerald BioStructures
Evotec
Kinetic Discovery
Proteros Fragments
Sprint Bioscience
Structure Based Design
Sygnature Discovery
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Fragment-based Drug Discovery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Fragment-based Drug Discovery, with revenue, gross margin and global market share of Fragment-based Drug Discovery from 2019 to 2021.
Chapter 3, the Fragment-based Drug Discovery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Fragment-based Drug Discovery market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Fragment-based Drug Discovery research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Fragment-based Drug Discovery
1.2 Classification of Fragment-based Drug Discovery by Type
1.2.1 Overview: Global Fragment-based Drug Discovery Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Fragment-based Drug Discovery Revenue Market Share by Type in 2020
1.2.3 Fragment Screening
1.2.4 Fragment Optimization
1.3 Global Fragment-based Drug Discovery Market by Application
1.3.1 Overview: Global Fragment-based Drug Discovery Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Academic and Research Institutions
1.3.3 Biopharmaceutical Companies
1.3.4 Contract Research Organizations (CROs)
1.4 Global Fragment-based Drug Discovery Market Size & Forecast
1.5 Global Fragment-based Drug Discovery Market Size and Forecast by Region
1.5.1 Global Fragment-based Drug Discovery Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Fragment-based Drug Discovery Market Size by Region, (2016-2021)
1.5.3 North America Fragment-based Drug Discovery Market Size and Prospect (2016-2026)
1.5.4 Europe Fragment-based Drug Discovery Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Fragment-based Drug Discovery Market Size and Prospect (2016-2026)
1.5.6 South America Fragment-based Drug Discovery Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Fragment-based Drug Discovery Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Fragment-based Drug Discovery Market Drivers
1.6.2 Fragment-based Drug Discovery Market Restraints
1.6.3 Fragment-based Drug Discovery Trends Analysis
2 Company Profiles
2.1 Astex Pharmaceuticals
2.1.1 Astex Pharmaceuticals Details
2.1.2 Astex Pharmaceuticals Major Business
2.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Product and Solutions
2.1.4 Astex Pharmaceuticals Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Astex Pharmaceuticals Recent Developments and Future Plans
2.2 Alveus Pharmaceuticals
2.2.1 Alveus Pharmaceuticals Details
2.2.2 Alveus Pharmaceuticals Major Business
2.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Product and Solutions
2.2.4 Alveus Pharmaceuticals Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Alveus Pharmaceuticals Recent Developments and Future Plans
2.3 Beactica
2.3.1 Beactica Details
2.3.2 Beactica Major Business
2.3.3 Beactica Fragment-based Drug Discovery Product and Solutions
2.3.4 Beactica Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Beactica Recent Developments and Future Plans
2.4 Charles River Laboratories
2.4.1 Charles River Laboratories Details
2.4.2 Charles River Laboratories Major Business
2.4.3 Charles River Laboratories Fragment-based Drug Discovery Product and Solutions
2.4.4 Charles River Laboratories Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Charles River Laboratories Recent Developments and Future Plans
2.5 Crown Bioscience
2.5.1 Crown Bioscience Details
2.5.2 Crown Bioscience Major Business
2.5.3 Crown Bioscience Fragment-based Drug Discovery Product and Solutions
2.5.4 Crown Bioscience Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Crown Bioscience Recent Developments and Future Plans
2.6 Emerald BioStructures
2.6.1 Emerald BioStructures Details
2.6.2 Emerald BioStructures Major Business
2.6.3 Emerald BioStructures Fragment-based Drug Discovery Product and Solutions
2.6.4 Emerald BioStructures Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Emerald BioStructures Recent Developments and Future Plans
2.7 Evotec
2.7.1 Evotec Details
2.7.2 Evotec Major Business
2.7.3 Evotec Fragment-based Drug Discovery Product and Solutions
2.7.4 Evotec Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Evotec Recent Developments and Future Plans
2.8 Kinetic Discovery
2.8.1 Kinetic Discovery Details
2.8.2 Kinetic Discovery Major Business
2.8.3 Kinetic Discovery Fragment-based Drug Discovery Product and Solutions
2.8.4 Kinetic Discovery Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Kinetic Discovery Recent Developments and Future Plans
2.9 Proteros Fragments
2.9.1 Proteros Fragments Details
2.9.2 Proteros Fragments Major Business
2.9.3 Proteros Fragments Fragment-based Drug Discovery Product and Solutions
2.9.4 Proteros Fragments Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Proteros Fragments Recent Developments and Future Plans
2.10 Sprint Bioscience
2.10.1 Sprint Bioscience Details
2.10.2 Sprint Bioscience Major Business
2.10.3 Sprint Bioscience Fragment-based Drug Discovery Product and Solutions
2.10.4 Sprint Bioscience Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Sprint Bioscience Recent Developments and Future Plans
2.11 Structure Based Design
2.11.1 Structure Based Design Details
2.11.2 Structure Based Design Major Business
2.11.3 Structure Based Design Fragment-based Drug Discovery Product and Solutions
2.11.4 Structure Based Design Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Structure Based Design Recent Developments and Future Plans
2.12 Sygnature Discovery
2.12.1 Sygnature Discovery Details
2.12.2 Sygnature Discovery Major Business
2.12.3 Sygnature Discovery Fragment-based Drug Discovery Product and Solutions
2.12.4 Sygnature Discovery Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Sygnature Discovery Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Fragment-based Drug Discovery Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Fragment-based Drug Discovery Players Market Share
3.2.2 Top 10 Fragment-based Drug Discovery Players Market Share
3.2.3 Market Competition Trend
3.3 Fragment-based Drug Discovery Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Fragment-based Drug Discovery Revenue and Market Share by Type (2016-2021)
4.2 Global Fragment-based Drug Discovery Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Fragment-based Drug Discovery Revenue Market Share by Application (2016-2021)
5.2 Fragment-based Drug Discovery Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Fragment-based Drug Discovery Revenue by Type (2016-2026)
6.2 North America Fragment-based Drug Discovery Revenue by Application (2016-2026)
6.3 North America Fragment-based Drug Discovery Market Size by Country
6.3.1 North America Fragment-based Drug Discovery Revenue by Country (2016-2026)
6.3.2 United States Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
6.3.3 Canada Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
6.3.4 Mexico Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Fragment-based Drug Discovery Revenue by Type (2016-2026)
7.2 Europe Fragment-based Drug Discovery Revenue by Application (2016-2026)
7.3 Europe Fragment-based Drug Discovery Market Size by Country
7.3.1 Europe Fragment-based Drug Discovery Revenue by Country (2016-2026)
7.3.2 Germany Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
7.3.3 France Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
7.3.5 Russia Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
7.3.6 Italy Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Fragment-based Drug Discovery Revenue by Type (2016-2026)
8.2 Asia-Pacific Fragment-based Drug Discovery Revenue by Application (2016-2026)
8.3 Asia-Pacific Fragment-based Drug Discovery Market Size by Region
8.3.1 Asia-Pacific Fragment-based Drug Discovery Revenue by Region (2016-2026)
8.3.2 China Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
8.3.3 Japan Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
8.3.4 South Korea Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
8.3.5 India Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
8.3.7 Australia Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Fragment-based Drug Discovery Revenue by Type (2016-2026)
9.2 South America Fragment-based Drug Discovery Revenue by Application (2016-2026)
9.3 South America Fragment-based Drug Discovery Market Size by Country
9.3.1 South America Fragment-based Drug Discovery Revenue by Country (2016-2026)
9.3.2 Brazil Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
9.3.3 Argentina Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Fragment-based Drug Discovery Revenue by Type (2016-2026)
10.2 Middle East & Africa Fragment-based Drug Discovery Revenue by Application (2016-2026)
10.3 Middle East & Africa Fragment-based Drug Discovery Market Size by Country
10.3.1 Middle East & Africa Fragment-based Drug Discovery Revenue by Country (2016-2026)
10.3.2 Turkey Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
10.3.4 UAE Fragment-based Drug Discovery Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Fragment-based Drug Discovery Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Fragment-based Drug Discovery Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Fragment-based Drug Discovery Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Fragment-based Drug Discovery Revenue (USD Million) by Region (2016-2021)
Table 5. Global Fragment-based Drug Discovery Revenue Market Share by Region (2021-2026)
Table 6. Astex Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 7. Astex Pharmaceuticals Major Business
Table 8. Astex Pharmaceuticals Fragment-based Drug Discovery Product and Solutions
Table 9. Astex Pharmaceuticals Fragment-based Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Alveus Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 11. Alveus Pharmaceuticals Major Business
Table 12. Alveus Pharmaceuticals Fragment-based Drug Discovery Product and Solutions
Table 13. Alveus Pharmaceuticals Fragment-based Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Beactica Corporate Information, Head Office, and Major Competitors
Table 15. Beactica Major Business
Table 16. Beactica Fragment-based Drug Discovery Product and Solutions
Table 17. Beactica Fragment-based Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Charles River Laboratories Corporate Information, Head Office, and Major Competitors
Table 19. Charles River Laboratories Major Business
Table 20. Charles River Laboratories Fragment-based Drug Discovery Product and Solutions
Table 21. Charles River Laboratories Fragment-based Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Crown Bioscience Corporate Information, Head Office, and Major Competitors
Table 23. Crown Bioscience Major Business
Table 24. Crown Bioscience Fragment-based Drug Discovery Product and Solutions
Table 25. Crown Bioscience Fragment-based Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Emerald BioStructures Corporate Information, Head Office, and Major Competitors
Table 27. Emerald BioStructures Major Business
Table 28. Emerald BioStructures Fragment-based Drug Discovery Product and Solutions
Table 29. Emerald BioStructures Fragment-based Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Evotec Corporate Information, Head Office, and Major Competitors
Table 31. Evotec Major Business
Table 32. Evotec Fragment-based Drug Discovery Product and Solutions
Table 33. Evotec Fragment-based Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Kinetic Discovery Corporate Information, Head Office, and Major Competitors
Table 35. Kinetic Discovery Major Business
Table 36. Kinetic Discovery Fragment-based Drug Discovery Product and Solutions
Table 37. Kinetic Discovery Fragment-based Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Proteros Fragments Corporate Information, Head Office, and Major Competitors
Table 39. Proteros Fragments Major Business
Table 40. Proteros Fragments Fragment-based Drug Discovery Product and Solutions
Table 41. Proteros Fragments Fragment-based Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Sprint Bioscience Corporate Information, Head Office, and Major Competitors
Table 43. Sprint Bioscience Major Business
Table 44. Sprint Bioscience Fragment-based Drug Discovery Product and Solutions
Table 45. Sprint Bioscience Fragment-based Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Structure Based Design Corporate Information, Head Office, and Major Competitors
Table 47. Structure Based Design Major Business
Table 48. Structure Based Design Fragment-based Drug Discovery Product and Solutions
Table 49. Structure Based Design Fragment-based Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Sygnature Discovery Corporate Information, Head Office, and Major Competitors
Table 51. Sygnature Discovery Major Business
Table 52. Sygnature Discovery Fragment-based Drug Discovery Product and Solutions
Table 53. Sygnature Discovery Fragment-based Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Fragment-based Drug Discovery Revenue (USD Million) by Players (2019-2021)
Table 55. Global Fragment-based Drug Discovery Revenue Share by Players (2019-2021)
Table 56. Breakdown of Fragment-based Drug Discovery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Fragment-based Drug Discovery Players Head Office, Products and Services Provided
Table 58. Fragment-based Drug Discovery Mergers & Acquisitions in the Past Five Years
Table 59. Fragment-based Drug Discovery New Entrants and Expansion Plans
Table 60. Global Fragment-based Drug Discovery Revenue (USD Million) by Type (2016-2021)
Table 61. Global Fragment-based Drug Discovery Revenue Share by Type (2016-2021)
Table 62. Global Fragment-based Drug Discovery Revenue Forecast by Type (2021-2026)
Table 63. Global Fragment-based Drug Discovery Revenue by Application (2016-2021)
Table 64. Global Fragment-based Drug Discovery Revenue Forecast by Application (2021-2026)
Table 65. North America Fragment-based Drug Discovery Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Fragment-based Drug Discovery Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Fragment-based Drug Discovery Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Fragment-based Drug Discovery Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Fragment-based Drug Discovery Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Fragment-based Drug Discovery Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Fragment-based Drug Discovery Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Fragment-based Drug Discovery Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Fragment-based Drug Discovery Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Fragment-based Drug Discovery Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Fragment-based Drug Discovery Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Fragment-based Drug Discovery Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Fragment-based Drug Discovery Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Fragment-based Drug Discovery Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Fragment-based Drug Discovery Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Fragment-based Drug Discovery Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Fragment-based Drug Discovery Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Fragment-based Drug Discovery Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Fragment-based Drug Discovery Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Fragment-based Drug Discovery Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Fragment-based Drug Discovery Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Fragment-based Drug Discovery Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Fragment-based Drug Discovery Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Fragment-based Drug Discovery Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Fragment-based Drug Discovery Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Fragment-based Drug Discovery Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Fragment-based Drug Discovery Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Fragment-based Drug Discovery Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Fragment-based Drug Discovery Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Fragment-based Drug Discovery Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Fragment-based Drug Discovery Picture
Figure 2. Global Fragment-based Drug Discovery Revenue Market Share by Type in 2020
Figure 3. Fragment Screening
Figure 4. Fragment Optimization
Figure 5. Fragment-based Drug Discovery Revenue Market Share by Application in 2020
Figure 6. Academic and Research Institutions Picture
Figure 7. Biopharmaceutical Companies Picture
Figure 8. Contract Research Organizations (CROs) Picture
Figure 9. Global Fragment-based Drug Discovery Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Fragment-based Drug Discovery Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Fragment-based Drug Discovery Revenue Market Share by Region (2016-2026)
Figure 12. Global Fragment-based Drug Discovery Revenue Market Share by Region in 2020
Figure 13. North America Fragment-based Drug Discovery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Fragment-based Drug Discovery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Fragment-based Drug Discovery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Fragment-based Drug Discovery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Fragment-based Drug Discovery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Fragment-based Drug Discovery Market Drivers
Figure 19. Fragment-based Drug Discovery Market Restraints
Figure 20. Fragment-based Drug Discovery Market Trends
Figure 21. Astex Pharmaceuticals Recent Developments and Future Plans
Figure 22. Alveus Pharmaceuticals Recent Developments and Future Plans
Figure 23. Beactica Recent Developments and Future Plans
Figure 24. Charles River Laboratories Recent Developments and Future Plans
Figure 25. Crown Bioscience Recent Developments and Future Plans
Figure 26. Emerald BioStructures Recent Developments and Future Plans
Figure 27. Evotec Recent Developments and Future Plans
Figure 28. Kinetic Discovery Recent Developments and Future Plans
Figure 29. Proteros Fragments Recent Developments and Future Plans
Figure 30. Sprint Bioscience Recent Developments and Future Plans
Figure 31. Structure Based Design Recent Developments and Future Plans
Figure 32. Sygnature Discovery Recent Developments and Future Plans
Figure 33. Global Fragment-based Drug Discovery Revenue Share by Players in 2020
Figure 34. Fragment-based Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Fragment-based Drug Discovery Revenue Market Share in 2020
Figure 36. Global Top 10 Players Fragment-based Drug Discovery Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Fragment-based Drug Discovery Revenue Share by Type in 2020
Figure 39. Global Fragment-based Drug Discovery Market Share Forecast by Type (2021-2026)
Figure 40. Global Fragment-based Drug Discovery Revenue Share by Application in 2020
Figure 41. Global Fragment-based Drug Discovery Market Share Forecast by Application (2021-2026)
Figure 42. North America Fragment-based Drug Discovery Sales Market Share by Type (2016-2026)
Figure 43. North America Fragment-based Drug Discovery Sales Market Share by Application (2016-2026)
Figure 44. North America Fragment-based Drug Discovery Revenue Market Share by Country (2016-2026)
Figure 45. United States Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Fragment-based Drug Discovery Sales Market Share by Type (2016-2026)
Figure 49. Europe Fragment-based Drug Discovery Sales Market Share by Application (2016-2026)
Figure 50. Europe Fragment-based Drug Discovery Revenue Market Share by Country (2016-2026)
Figure 51. Germany Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Fragment-based Drug Discovery Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Fragment-based Drug Discovery Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Fragment-based Drug Discovery Revenue Market Share by Region (2016-2026)
Figure 59. China Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Fragment-based Drug Discovery Sales Market Share by Type (2016-2026)
Figure 66. South America Fragment-based Drug Discovery Sales Market Share by Application (2016-2026)
Figure 67. South America Fragment-based Drug Discovery Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Fragment-based Drug Discovery Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Fragment-based Drug Discovery Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Fragment-based Drug Discovery Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Fragment-based Drug Discovery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
